<scp>CD39</scp> pathway inhibits Th1 cell function in tuberculosis
Ying Luo(Southwestern Medical Center), Feng Wang(Tongji Hospital), Wei Liu(AbbVie (United States)), Huijuan Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Xue(Tongji Hospital), Sun Ziyong(Tongji Hospital), Liyan Mao(Tulane University), Guoxing Tang(Tongji Hospital), Qun Lin(Tongji Hospital)
Cited by 10
Related Papers
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
|Clinical & Translational Immunology|2020|415
Cohort Profile: The Dongfeng–Tongji cohort study of retired workers
|International Journal of Epidemiology|2012|295
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
|Arthritis & Rheumatology|2019|215
Risk factors for postoperative pneumonia after cardiac surgery: a prediction model
|Journal of Thoracic Disease|2021|85
Review and Updates on the Diagnosis of Tuberculosis
|Journal of Clinical Medicine|2022|75